the propensity of these ( arylalkyl ) imidazole anticonvulsants to interact strongly with cytochrome p-450 and thereby impair the metabolism of other antiepileptic drugs may severely limit their clinical utility as anticonvulsants .
C0010762
cytochrome p-450
C0025519
metabolism